Close Menu

NEW YORK – Clinical Reference Laboratory (CRL) said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for a saliva-based COVID-19 RT-PCR test that allows for unsupervised self-collection of samples.

According to the company, the test, CRL Rapid Response, has shown to be more sensitive and accurate than a COVID-19 anterior nasal swab test in the firm's EUA validation study. Test results are available within 24 to 48 hours of sample receipt.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.